Advancing a New Approach to Middle-Ear Assessment
OtoNexus Medical Technologies is developing an ultrasound otoscope to provide objective information about middle-ear conditions during a routine ear examination. The platform combines proprietary through-air ultrasound technology with AI-assisted signal analysis to support more timely, informed clinical decision-making, with the goal of reducing time to diagnosis, supporting the judicious use of antibiotics, and helping reduce the costs associated with diagnostic uncertainty and unnecessary care.
Investigational device. Not cleared by the FDA. Not available for commercial sale.
A Differentiated Technology Platform
Bringing Ultrasound to the Ear Exam
OtoNexus is developing proprietary technology that applies through-air ultrasound to middle-ear assessment in a compact otoscope platform.
The system is being designed to collect ultrasound information during the ear examination and use AI-assisted signal analysis to provide objective information to support clinical decision-making.
This combination of ultrasound sensing, AI-assisted analysis, and an otoscope-based workflow represents a differentiated approach to addressing diagnostic uncertainty in middle-ear conditions.
Why the Opportunity Matters
Addressing an Important Clinical Challenge
Middle-ear conditions are common, particularly in children, yet evaluation can depend on clinical findings that may be difficult to assess consistently during a routine ear examination.
OtoNexus is developing its technology to add objective information to this process, with three broader healthcare goals:
More Timely Decisions
Provide objective information during the patient visit to support more timely clinical decision-making.
Antibiotic Stewardship
Support informed treatment decisions and the judicious use of antibiotics.
Healthcare Efficiency
Help address costs associated with diagnostic uncertainty and unnecessary care.
Built Around a Simple Clinical Concept
Position. Scan. Analyze. Inform.
Opportunities for Strategic Collaboration
Building Relationships That Can Help Advance the Technology
OtoNexus is interested in strategic relationships that can complement the development and future potential of its through-air ultrasound platform. We welcome conversations with organizations whose capabilities, technologies, market presence, or strategic interests may align with our development objectives.
Clinical & Research Collaboration
Engagement with clinicians, researchers, and healthcare organizations interested in advancing the understanding and evaluation of middle-ear diagnostic technologies.
Technology & Product Development
Potential collaboration around sensing, artificial intelligence, software, connectivity, product development, and related technology areas.
Manufacturing & Scale-Up
Relationships that may support future manufacturing readiness, supply chain development, and scalable production.
Commercialization
Exploration of future opportunities related to market development, distribution, commercialization, and strategic alignment.
Platform Development
Exploration of additional applications for OtoNexus technology where through-air ultrasound and signal analysis may offer strategic value.
Why Partner with OtoNexus?
Proprietary Technology
A differentiated through-air ultrasound approach being developed to provide objective information about middle-ear conditions.
Intellectual Property
A growing intellectual-property portfolio supporting the OtoNexus technology platform.
Multidisciplinary Expertise
Experience spanning ultrasound, artificial intelligence, medical-device development, clinical research, regulatory strategy, product development, and commercialization.
Platform Potential
A technology platform with potential applications extending beyond the company's initial focus on middle-ear assessment.
Advancing Through Development
OtoNexus continues to advance the ultrasound otoscope through engineering, clinical, regulatory, and commercialization-readiness activities, including participation in the FDA Safer Technologies Program.
Investigational device. Not cleared by the FDA. Not available for commercial sale.
Let's Explore What's Possible
Interested in exploring a strategic relationship with OtoNexus?
We welcome conversations with organizations whose capabilities and strategic interests may align with the development and future potential of the OtoNexus technology platform.